1 / 42

Rheumatology Basics

Rheumatology Basics. Kalyani McCullough, MD Clinics and MOP Didactic. Purpose of this talk. To provide a foundation for: Seeing patients in Rheumatology clinic Getting started on the work-up of suspected rheumatologic diseases in your clinic Review most common rheumatologic diseases

ike
Download Presentation

Rheumatology Basics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Rheumatology Basics Kalyani McCullough, MD Clinics and MOP Didactic

  2. Purpose of this talk • To provide a foundation for: • Seeing patients in Rheumatology clinic • Getting started on the work-up of suspected rheumatologic diseases in your clinic • Review most common rheumatologic diseases • Fast overview • Resource for later

  3. Main diseases you’ll be seeing • Inflammatory arthritis • Rheumatoid, spondyloarthropathies • Crystal arthritis • Gout, Pseudogout • Autoimmune disorders • Lupus, Sclerodema, Autoimmune myositis • Vasculitis • Large, medium, small vessel

  4. What are some clues your patient may have a rheumatologic disease? • Constitutional symptoms • Fevers, sweats, weight loss, fatigue • Subacute time course • Started over weeks to months • Characteristic symptoms • Mono or polyarticular joint pain, multisystem complaints (i.e. skin, lung, GI) • Are there signs of an inflammatory process? • Synovitis, rash, serositis, elevated ESR/CRP

  5. How do you get started on the work-up? • Thorough physical exam • Lab tests • CBC w diff, ESR, CRP, ANA, targeted autoantibodies • Radiographs • Erosive arthritis, sacroillitis • Biopsy? • Skin, muscle, kidney

  6. Basics of treatment • NSAIDs • Symptom relief, especially joint pain • Glucocorticoids • Acutely, try to use steroid sparing agent if possible • Disease-modifying antirheumatic drugs (DMARDs) • Synthetic DMARDs • Slow onset, 2-6 months • Methotrexate, Hydroxychloroquine, Sulfasalazine, Azathioprine, Mycophenolate mofetil, Cyclophosphamide • Biologic DMARDs • Bioengineered protein drugs (antibodies or receptor-antibody chimeras ) • IV or SQ only • Rapid onset • Screen for and treat LTBI, HBV first • Infliximab, Etancercept, Rituximab

  7. Steroid Side Effects • Weight gain • Diabetes • Cataracts • Insomnia • Fluid retention • Hypertension • Proximal weakness • Alopecia • Sweats • Osteoporosis • Infection • Psychiatric disturbance (eg, depression, mania, psychosis) • Easy bruising of the skin • Stress • Tremor • Peptic ulcer disease

  8. Long term considerations for most autoimmune diseases • Increased risk of CV death due to inflammation and accelerated atherosclerosis • Aggressive risk factor reduction: BP<120/80, LDL<100 • Osteoporosis from glucocorticoids • Dexa screening, Calcium-Vit D, bisphosphonates prn • Infections • Increased risk of certain malignancies • Lymphoma, Lung/Cervical CA in Lupus

  9. Inflammatory Arthritis • Rheumatoid arthritis • Spondyloarthropathies • Axial skeletal involvement and polyarthritis of peripheral joints • Ankylosing spondylitis • Reactive arthritis • Psoriatic arthritis • IBD-associated arthritis

  10. Rheumatoid arthritis • Clinical presentation: • Chronic, symmetric polyarthritis • Often starts with the PIPs, MCPs, MTPs • Can affect most synovial joints (wrists, knees, elbows etc.) • Doesn’t affect DIPs • Morning stiffness, pain, swelling (vs. OA: worse with activity) • Labs: • RF, anti-CCP Ab or both in 70% of patients • RF not specific, anti-CCP 90-98% specific • ACD, ESR, CRP • Xrays: • articular erosions and joint space narrowing

  11. Joint distribution in RA vs. OA

  12. RA – Physical Exam Findings • Ulnar deviation • at mcps • Swan neck deformity • hyperextension of PIPs, flexion of DIPs • Boutonniere deformity • flexion of PIP, hyperextension of DIP

  13. OA – Physical Exam Findings Bony outgrowths/ calcific spurs on PIPs and DIPs

  14. RA – Extra-articular Manifestations • Many extra-articular findings: • Rheumatoid nodules • Other organ involvement: • Sjogren’s syndrome • Scleritis • Interstitial fibrosis • Pericardial effusions • Peripheral neuropathy • Amyloidosis

  15. RA - Treatment • Early aggressive treatment leads to better longterm outcomes • Glucocorticoids acutely • MTX frequently used • Start 7.5mg weekly, increase to a max dose of 20-25mg weekly • Give with folate 1mg daily to reduce toxicity • Check CBC, AST/ALT, Cr q 3 mo • Contraindications: liver disease, HBV/HCV, alcohol use, CrCl<30 • Toxicities: oral ulcers, nausea, hepatotoxicity, BMS, pneumonitis

  16. Sponydloarthropathies • Inflammatory arthritis with involvement of: • Sacroiliac (SI) joint • Axial spine • Tendon fascia • Ligament insertion points (entheses) • Peripheral joints

  17. Spondyloarthropathies • Ankylosing Spondylitis • Psoriatic Arthritis • DIPs often involved, assoc with nail pitting • Reactive Arthritis • Triggered by GI/GU infection • IBD-associated arthritis • Correlates with bowel activity

  18. Ankylosing Spondylitis • Clinical presentation • Inflammatory back pain in young adult • Reduction in spinal mobility, particularly lumbar flexion • Association with anterior uveitis • Labs • Increased relative risk of HLA-B27 • Xray • - Sacroiliitis • Treatment • - PT, NSAIDs

  19. Crystal Arthritis Gout – Natural History 1) Asymptomatic hyperuricemia • Over production or under excretion (or both) 2) Acute and intermittent gout • Attacks triggered by fluctuations in UA level (up or down) and deposition of UA crystals in joint • Acute monoarthritis, often 1st attack is at 1st mtp • After years see bony erosions on xray 3) Chronic tophaceous gout

  20. Gout - Treatment • Acute attack – most efficacious if initiate treatment within 48h of onset • NSAIDs – indomethacin • Avoid if h/o PUD or renal impairment • Colchisine • 1.2mg PO x 1, then 0.6mg 1h later and q24h until symptoms improve • Side effects: Diarrhea, abdominal pain, NSAIDs better tolerated • Reduce dose if Cr > 1.5, risk of neuromuscular toxicity • Glucocorticoids • Prednisone 20-40mg/d, taper 1-2 wks after symptoms resolve

  21. Gout - Prophylaxis • Goal UA<6 • Xanthine oxidase inhibitors (decrease production) • Allopurinol • Start with 100mg daily, gradually increase dose • Max is 800mg/d, though 300-400mg usually effective • Reduce dose if diminished Cr • Hypersensitivity reaction can be fatal, more common in older patients with impaired Cr on diuretics • If develop rash, stop • Febuxostat • Metabolized by liver, so better with renal impairment • Ok with mild-moderate hepatic insufficiency • Uricosuric agents (increase excretion) • Probenacid • Age <65, good renal function, not on more than ASA 81 daily • Side effects: rash and GI symptoms

  22. Pseudogout • Clinical presentation • Intermittent monoarthritis, often knee/wrist, though can be 1st mtp • Labs • rhomboid shaped, positively birefringent calcium pyrophosphate dihydrate (CPPD) crystals • Can be associated with other diseases: hemochromatosis, thyroid disease • Treatment • NSAIDs, colchisine

  23. Autoimmune disorders • Systemic lupus erythematosis (SLE) • Antiphospholipid antibody syndrome • Raynaud’s phenomenon • Scleroderma • Sjogren’s Disease • Dermatomyositis and Polymyositis • Relapsing Polychondritis

  24. Lupus • Clinical presentation • Typically affects women of childbearing age • Multisystem relapsing/remitting disease • Affects skin, musculoskeletal, renal, CV, pulmonary, GI, CNS, psych • - Hallmark symptoms: photosensitive rash, polyarthritis, serositis, fatigue • - Renal and CNS involvement -> significant morbidity

  25. Lupus • Labs • Presence of antinuclear antibodies • Once ANA positive, no need to recheck • Anti-dsDNA and anti-Sm have great specificity, but lack sensitivity. • Hypocomplementemia may occur during flares. • C3, C4, CH50 • Treatment • Glucocorticoids, DMARDs

  26. Lupus - Monitoring • Lupus nephritis – approx 50% • Typically immune complex glomerulonephritis • Screen q3 mo: • Ask about polyuria, nocturia, foamy urine • Look for HTN and edema • Labs: UA – RBC casts, spot prot: Cr ratio • Diagnose with biopsy • Increased risk of malignancy: Hodkin’s and Non-Hodgkins lymphoma, Lung CA, Cervical CA • Annual cervical CA screening

  27. Scleroderma • Clinical presentation • Early in disease: • msk pain, fatigue, weight loss, GERD • Rare disorder, but symptoms common in primary care • Late in disease: • Skin: thickening, ischemic digital ulcers, pitting, telangectasias on face and palms • Lungs: interstitial fibrosis, pulmonary htn • GI: GERD, dysphagia • Renal: rare, but Scleroderma Renal Crisis (SRC) is life threatening emergency • Cardiac: ischemic injury • MSK: erosive arthritis, tendon friction rub • CREST (limited scleroderma): calcinosis, raynaud’s, esophageal dysmotility, sclerodactyly, telangectasias

  28. Scleroderma Thickened, tight skin Digital ulcers Sclerodactyly Telangectasias

  29. Scleroderma • Labs • If negative ANA, diagnosis is very unlikely • Indirect immunofluorescence better than ELISA • Anti-centromere Ab in 20-40% • Anti-Scl-70 (anti-topoisomerase) 20-40% • Correlates with worse prognosis • Treatment • No proven disease-modifying medication • Screening and early identification of internal organ involvement important • Organ specific treatment • Fibrosis – immunosuppresion • Renal crisis – ACEi • GERD – PPI and behavioral change

  30. Autoimmune myositis • Polymyositis (PM) • Dermatomyositis • Dermatomyositis sine myositis (just skin) • Dermatomyositis sine dermatitis (classic muscle biopsy findings) • Immune-mediated necrotizing myopathy (IMNM) • Statin exposure

  31. Autoimmune myositis • Clinical presentation • Symmetric, proximal muscle weakness that develops over weeks to months • Difficulty rising from a chair, walking up steps, washing or brushing hair • If severe: dysphagia and respiratory distress from weakness of neck, pharyngeal and diapghragmatic muscles • Distal weakness very uncommon, suspect another diagnosis

  32. Dermatomyositis • Clinical Presentation: Skin • Gottron papules: raised violaceous lesions at extensor surfaces of mcp, pip, dip • Gottron sign: erythematous rash at above sites • Heliotrope rash: red/purplish discoloration of eyelids

  33. Dermatomyositis • Shawl sign: erythematous rash across posterior neck and shoulders • V sign: erythematous rash on anterior neck and chest • Mechanic’s hands/feet: hyperkeratotic skin thickening, often with painful cracking

  34. Autoimmune myositis • Labs • Elevated CK, aldolase, AST, ALT, LD from damaged muscle cells • Auto antibodies (anti-Jo-1, anti PL-7) • ANA positive in >50% • Antisynthetase syndrome in dermatomysoitis: also with ILD, arthritis, fevers, raynaud’s • MRI: muscle edema, fascial inflammation • EMG: irritable myopathy • Muscle biopsy: generally nonspecific findings, but rules out non-autoimmune myopathies • DM: perifascicular atrophy is specific

  35. Autoimmune myositis • Treatment • Glucocorticoids to control acute disease • Taper to lowest effective dose • Steroid sparing agent: MTX, azathioprine • Exercise: especially isometric, avoid heavy weight lifting

  36. Autoimmune myositis vs. PMR • Polymyalgia Rheumatica (PMR) • aching and stiffness of neck, shoulders, hips (vs. weakness) • Elevated ESR >40 • Age >50 • Rapid response to prednisone 20mg/d or less • Association with GCA, but can occur independently too

  37. Mixed Connective Tissue Disease • Overlap syndrome with features of SLE, Scleroderma and Polymyositis • Characteristic clinical symptoms: • Raynaud phenomenon, hand edema, synovitis, inflammatory muscle disease, sclerodactyly • High titers of anti-U1 RNP autoantibody

  38. Vasculitis • Inflammatory destruction of blood vessels • Occlusion, rupture, thrombus can lead to tissue ischemia • Vary in severity and presentation based on vessels affected

  39. Vasculitis • Clinical presentation • Constitutional symptoms • Subacute • Signs of inflammation • Multisystem disease • i.e. Mononeuritis multiplex • Distinct/named peripheral nerves infarcted one at a time • Due to vasculitis of vasa nervorum leading to ischemia • Hallmarks are asynchrony and asymmetry • Labs • Diagnose with biopsy • Treatment • Disease specific, often immunosuppressive therapy

  40. In Summary • Suspect a rheumatologic process in patients with subacute onset of constitutional symptoms, signs of inflammation and multi system involvement • Get work-up started with thorough PE, targeted labs and xrays • Consult with Rheum and consider getting prednisone started to control acute disease, with a goal of tapering to the lowest effective dose when possible • Monitor for the longterm complications of autoimmune disease

  41. Questions?

More Related